| Product Code: ETC13131070 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Non-Opioid Pain Treatment Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Non-Opioid Pain Treatment Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Non-Opioid Pain Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Non-Opioid Pain Treatment Market - Industry Life Cycle |
3.4 Europe Non-Opioid Pain Treatment Market - Porter's Five Forces |
3.5 Europe Non-Opioid Pain Treatment Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Non-Opioid Pain Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Europe Non-Opioid Pain Treatment Market Revenues & Volume Share, By Therpaeutic application, 2021 & 2031F |
3.8 Europe Non-Opioid Pain Treatment Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F |
4 Europe Non-Opioid Pain Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Non-Opioid Pain Treatment Market Trends |
6 Europe Non-Opioid Pain Treatment Market, 2021 - 2031 |
6.1 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Medical Cannabis, 2021 - 2031 |
6.1.3 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Menthol-Containing, 2021 - 2031 |
6.1.4 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Omega 3 Fatty Acid-Containing, 2021 - 2031 |
6.1.5 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Botulinum Toxins, 2021 - 2031 |
6.1.6 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Capsaicin-Derived, 2021 - 2031 |
6.1.7 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Therpaeutic application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Orthopaedic and Musculoskeletal Pain, 2021 - 2031 |
6.2.3 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Neuropathic Pain, 2021 - 2031 |
6.2.4 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Cancer Pain, 2021 - 2031 |
6.2.5 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Post-operative Pain, 2021 - 2031 |
6.2.6 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Hospitals Pharmacies, 2021 - 2031 |
6.3.3 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.3.4 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Drug Stores, 2021 - 2031 |
6.3.5 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Mail Order Pharmacies, 2021 - 2031 |
7 Europe Non-Opioid Pain Treatment Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.1 United Kingdom (UK) Non-Opioid Pain Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.2 Germany Non-Opioid Pain Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.3 France Non-Opioid Pain Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.4 Poland Non-Opioid Pain Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.5 Spain Non-Opioid Pain Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.6 Rest of Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3 Europe Non-Opioid Pain Treatment Market Revenues & Volume Share, By Therpaeutic application, 2021 & 2031F |
7.3.1 United Kingdom (UK) Non-Opioid Pain Treatment Market, Revenues & Volume, By Therpaeutic application, 2021 - 2031 |
7.3.2 Germany Non-Opioid Pain Treatment Market, Revenues & Volume, By Therpaeutic application, 2021 - 2031 |
7.3.3 France Non-Opioid Pain Treatment Market, Revenues & Volume, By Therpaeutic application, 2021 - 2031 |
7.3.4 Poland Non-Opioid Pain Treatment Market, Revenues & Volume, By Therpaeutic application, 2021 - 2031 |
7.3.5 Spain Non-Opioid Pain Treatment Market, Revenues & Volume, By Therpaeutic application, 2021 - 2031 |
7.3.6 Rest of Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Therpaeutic application, 2021 - 2031 |
7.4 Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
7.4.1 United Kingdom (UK) Non-Opioid Pain Treatment Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
7.4.2 Germany Non-Opioid Pain Treatment Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
7.4.3 France Non-Opioid Pain Treatment Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
7.4.4 Poland Non-Opioid Pain Treatment Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
7.4.5 Spain Non-Opioid Pain Treatment Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
7.4.6 Rest of Europe Non-Opioid Pain Treatment Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
8 Europe Non-Opioid Pain Treatment Market Key Performance Indicators |
9 Europe Non-Opioid Pain Treatment Market - Export/Import By Countries Assessment |
10 Europe Non-Opioid Pain Treatment Market - Opportunity Assessment |
10.1 Europe Non-Opioid Pain Treatment Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Non-Opioid Pain Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
10.3 Europe Non-Opioid Pain Treatment Market Opportunity Assessment, By Therpaeutic application, 2021 & 2031F |
10.4 Europe Non-Opioid Pain Treatment Market Opportunity Assessment, By Distribution channel, 2021 & 2031F |
11 Europe Non-Opioid Pain Treatment Market - Competitive Landscape |
11.1 Europe Non-Opioid Pain Treatment Market Revenue Share, By Companies, 2022 |
11.2 Europe Non-Opioid Pain Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here